Serum lipids and proliferative diabetic retinopathy and macular edema in persons with long-term type 1 diabetes mellitus: The Wisconsin epidemiologic study of diabetic retinopathy

JAMA Ophthalmology

Volumn 133, Issue 5, 2015, Pages 503-510

  Klein, Barbara E K ^a   Myers, Chelsea E ^a   Howard, Kerri P ^a,b   Klein, Ronald ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b American Family Insurance   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; CHOLESTEROL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; ARTICLE; DIABETIC PATIENT; DISEASE ASSOCIATION; DISEASE DURATION; DRUG USE; END STAGE RENAL DISEASE; FEMALE; FOLLOW UP; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIPID BLOOD LEVEL; MACULAR EDEMA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; PROLIFERATIVE DIABETIC RETINOPATHY; UNITED STATES; BLOOD; DIABETES MELLITUS, TYPE 1; DIABETIC RETINOPATHY; INCIDENCE; METABOLISM; PREVALENCE;

ADULT; CHOLESTEROL; CHOLESTEROL, HDL; DIABETES MELLITUS, TYPE 1; DIABETIC RETINOPATHY; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INCIDENCE; MACULAR EDEMA; MALE; MIDDLE AGED; PREVALENCE; WISCONSIN;

EID: 84929687474     PISSN: 21686165     EISSN: 21686173     Source Type: Journal    
DOI: 10.1001/jamaophthalmol.2014.5108     Document Type: Article

References (35)

1. Klein R, Klein BE, Moss SE. Visual impairment in diabetes. Ophthalmology. 1984;91(1):1-9.
2. Chew EY, Klein ML, Ferris FL III, et al. Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy: Early Treatment Diabetic Retinopathy Study (ETDRS) report 22. Arch Ophthalmol. 1996;114(9):1079-1084.
3. Miljanovic B, Glynn RJ, Nathan DM, Manson JE, Schaumberg DA. A prospective study of serum lipids and risk of diabetic macular edema in type 1 diabetes. Diabetes. 2004;53(11):2883-2892.
4. Klein BE, Klein R, Moss SE. Is serum cholesterol associated with progression of diabetic retinopathy or macular edema in persons with younger-onset diabetes of long duration? Am J Ophthalmol. 1999;128(5):652-654.
5. Mann DM, Woodward M, Ye F, Krousel-Wood M, Muntner P. Trends in medication use among US adults with diabetes mellitus: glycemic control at the expense of controlling cardiovascular risk factors. Arch Intern Med. 2009;169(18):1718-1720.
6. Klein R, Klein BE. Are individuals with diabetes seeing better? a long-term epidemiological perspective. Diabetes. 2010;59(8):1853-1860.
7. Antonetti DA, Klein R, Gardner TW. Diabetic retinopathy. N Engl J Med. 2012;366(13):1227-1239.
8. Klein BE, Howard KP, Klein R. Relationships of serum total cholesterol (total-C) and high density lipoprotein cholesterol (HDLC) with risk of proliferative diabetic retinopathy (PDR) and diabetic macular edema (DME) in persons with long term type 1 diabetes (T1D): the Wisconsin Epidemiologic Study of Diabetic Retinopathy (WESDR) [abstract]. Invest Ophthalmol Vis Sci. 2014;55: -Abstract-5350.
9. Klein R, Klein BE, Moss SE, De Mets DL, Kaufman I, Voss PS. Prevalence of diabetes mellitus in southern Wisconsin. Am J Epidemiol. 1984;119(1):54-61.
10. Klein R, Klein BE, Moss SE, Davis MD, De Mets DL. The Wisconsin epidemiologic study of diabetic retinopathy II: prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol. 1984;102(4):520-526.
11. Klein R, Klein BE, Moss SE, Davis MD, De Mets DL. The Wisconsin epidemiologic study of diabetic retinopathy III: prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol. 1984;102(4):527-532.
12. Klein R, Klein BE, Moss SE, Davis MD, De Mets DL. The Wisconsin Epidemiologic Study of Diabetic Retinopathy IX: four-year incidence and progression of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol. 1989;107(2):237-243.
13. Klein R, Klein BE, Moss SE, Cruickshanks KJ. The Wisconsin Epidemiologic Study of diabetic retinopathy XIV: ten-year incidence and progression of diabetic retinopathy. Arch Ophthalmol. 1994;112(9):1217-1228.
14. Klein R, Klein BE, Moss SE, Cruickshanks KJ. The Wisconsin Epidemiologic Study of Diabetic Retinopathy XVII: the 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Ophthalmology. 1998;105(10):1801-1815.
15. Hoerger TJ, Segel JE, Gregg EW, Saaddine JB. Is glycemic control improving in U. S. adults? Diabetes Care. 2008;31(1):81-86.
16. Klein R, Knudtson MD, Lee KE, Gangnon R, Klein BE. The Wisconsin Epidemiologic Study of Diabetic Retinopathy XXII: the twenty-five-year progression of retinopathy in persons with type 1 diabetes. Ophthalmology. 2008;115(11):1859-1868.
17. Klein BE, Klein R, McBride PE, et al. Cardiovascular disease, mortality, and retinal microvascular characteristics in type 1 diabetes: Wisconsin Epidemiologic Study of Diabetic Retinopathy. Arch Intern Med. 2004;164(17):1917-1924.
18. Klein R, Klein BE. Vision disorders in diabetes. In: Harris MI, Cowie CC, Stern MP, Boyko EJ, Reiber GE, Bennett PH, eds. Diabetes in America, 2nd Ed. Bethesda, MD: National Institutes of Health. NIH Publication No. 95-1468;1995:293-338.
19. The Hypertension Detection and Follow-up Program; Hypertension Detection and Follow-up Program Cooperative Group. The Hypertension Detection and Follow-up Program: Hypertension Detection and Follow-up Program Cooperative Group. Prev Med. 1976;5(2):207-215.
20. Early Treatment Diabetic Retinopathy Study (ETDRS) Research Group. Chapter 12: procedures for completing eye examinations. In: Early Treatment Diabetic Retinopathy Study (ETDRS) Manual of Operations. Springfield, VA: US Department of Commerce. NTIS Accession No. PB-85223006;1985:101-119.
21. Early Treatment Diabetic Retinopathy Study (ETDRS) Research Group. Chapter 18: classification of diabetic retinopathy from stereo color fundus photographs. In: Early Treatment Diabetic Retinopathy Study (ETDRS) Manual of Operations. Springfield, VA: US Department of Commerce. NTIS Accession No. PB-85223006;1985:207-243.
22. Lopes-Virella MF, Stone P, Ellis S, Colwell JA. Cholesterol determination in high-density lipoproteins separated by three different methods. Clin Chem. 1977;23(5):882-884.
23. Abel LL, Levy BB, Brodie BB, Kendall FE. A simplified method for the estimation of total cholesterol in serum and demonstration of its specificity. J Biol Chem. 1952;195(1):357-366.
24. Early Treatment Diabetic Retinopathy Study Research Group. Grading diabetic retinopathy from stereoscopic color fundus photographs: an extension of the modified Airlie House classification. ETDRS report number 10. Ophthalmology. 1991;98(5) (suppl):786-806.
25. Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema: Early Treatment Diabetic Retinopathy Study report number 1. Arch Ophthalmol. 1985;103(12):1796-1806.
26. Simic I, Pecin I, Tedeschi-Reiner E, Zrinscak O, Sucur N, Reiner Z. Risk factors for microvascular atherosclerotic changes in patients with type 2 diabetes mellitus. Coll Antropol. 2013;37(3):783-787.
27. Kordonouri O, Danne T, Hopfenmüller W, Enders I, Hövener G, Weber B. Lipid profiles and blood pressure: are they risk factors for the development of early background retinopathy and incipient nephropathy in children with insulin-dependent diabetes mellitus? Acta Paediatr. 1996;85(1):43-48.
28. Romero P, Salvat M, Fernández J, Baget M, Martinez I. Renal and retinal microangiopathy after 15 years of follow-up study in a sample of Type 1 diabetes mellitus patients. J Diabetes Complications. 2007;21(2):93-100.
29. Klein BE, Moss SE, Klein R, Surawicz TS. The Wisconsin Epidemiologic Study of Diabetic Retinopathy, XIII: relationship of serum cholesterol to retinopathy and hard exudate. Ophthalmology. 1991;98(8):1261-1265.
30. Cetin EN, Bulgu Y, Ozdemir S, et al. Association of serum lipid levels with diabetic retinopathy. Int J Ophthalmol. 2013;6(3):346-349.
31. Pasternak RC, Smith SC Jr, Bairey-Merz CN, Grundy SM, Cleeman JI, Lenfant C; American College of Cardiology; American Heart Association; National Heart, Lung and Blood Institute. ACC/AHA/NHLBI clinical advisory on the use and safety of statins. J Am Coll Cardiol. 2002;40(3):567-572.
32. Macisaac RJ, Ekinci EI, Jerums G. Markers of and risk factors for the development and progression of diabetic kidney disease. Am J Kidney Dis. 2014;63(2) (suppl 2):S39-S62.
33. Klein BE, Knudtson MD, Tsai MY, Klein R. The relation of markers of inflammation and endothelial dysfunction to the prevalence and progression of diabetic retinopathy: Wisconsin Epidemiologic Study of Diabetic Retinopathy. Arch Ophthalmol. 2009;127(9):1175-1182.
34. Behradmanesh S, Horestani MK, Baradaran A, Nasri H. Association of serum uric acid with proteinuria in type 2 diabetic patients. J Res Med Sci. 2013;18(1):44-46.
35. Chew EY, Ambrosius WT, Davis MD, et al; ACCORD Study Group; ACCORD Eye Study Group. Effects of medical therapies on retinopathy progression in type 2 diabetes. N Engl J Med. 2010;363(3):233-244.